Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Chiharu Tanai"'
Autor:
Kazuhiro Usui, Tomonori Ushijima, Yoshiaki Tanaka, Chiharu Tanai, Hiromichi Noda, Norifumi Abe, Hajime Horiuchi, Teruo Ishihara
Publikováno v:
Pulmonary Medicine, Vol 2011 (2011)
Background. Although epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are effective in patients with nonsmall cell lung cancer with epidermal growth factor receptor (EGFR) mutation, EGFR-TKIs have a risk of inducing fatal inter
Externí odkaz:
https://doaj.org/article/da0825cae47f42f68f590f3db5ff0f98
Autor:
Makoto Nishio, Akira Inoue, Yasushi Goto, Yoshinori Hasegawa, Chiharu Tanai, Hideo Kunitoh, Yasuo Ohashi, Kazuhiko Yamada, Yoshio Tomizawa, Yukio Hosomi, Young Hak Kim, Hiroshi Isobe, Koichi Minato, Yoshiaki Mori, Terufumi Kato, Kiyotaka Yoh, Takayuki Kaburagi, Hiroshi Sakai
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:1049-1056
This study aimed to analyze the characteristics and outcomes of patients suffering from non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor mutations (EGFRm+) receiving gefitinib who remained clinically stable following confirmat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b718db91815a27737058ef419512dacd
https://doi.org/10.1080/14656566.2018.1484903
https://doi.org/10.1080/14656566.2018.1484903
Autor:
Yoichi Naito, Kazuma Kishi, Yasushi Goto, Chiharu Tanai, Yoshio Tomizawa, Akira Inoue, Yasuo Ohashi, Makoto Nishio, Yoshinori Hasegawa, Kazuhiko Yamada, Kiyotaka Yoh, Hideo Kunitoh, Yukio Hosomi, Katsuyuki Hotta, Kiyoshi Mori
Publikováno v:
Anticancer Research. 37:1507-1514
Background The purpose of this study was to explore the role of maintenance therapy for patients with advanced non-small cell lung cancer (NSCLC) in a real-world setting. Patients and methods This was a prospective observational cohort multicenter st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efe8c3faf52a6a4c6a734e3ac83382e
https://doi.org/10.21873/anticanres.11478
https://doi.org/10.21873/anticanres.11478
Autor:
Yoshiaki Tanaka, Sayaka Ohara, Kazuhiro Usui, Chiharu Tanai, Hiromichi Noda, Hajime Horiuchi, Yoko Tazawa
Publikováno v:
Respiratory Investigation. 54:92-97
Background With advancements in anti-fungal drugs, it has become more important to correctly diagnose chronic pulmonary aspergillosis (CPA); however, it is not easy to distinguish CPA from colonization when Aspergillus species are isolated from respi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5db152d1d4f82d21672577221e8cec9a
https://doi.org/10.1016/j.resinv.2015.08.007
https://doi.org/10.1016/j.resinv.2015.08.007
Autor:
Kazuhiro Usui, Sayaka Ohara, Chiharu Tanai, Hiromichi Noda, Yoshiaki Tanaka, Tomonori Ushijima, Hajime Horiuchi
Publikováno v:
Haigan. 53:324-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcf286b152e5e7237b7340d2b09c16f0
https://doi.org/10.2482/haigan.53.324
https://doi.org/10.2482/haigan.53.324
Publikováno v:
Japanese Journal of Clinical Oncology. 41:498-502
Objective: Interstitial lung disease in patients with colorectal cancer during chemotherapy combined with bevacizumab is rare. Methods: We reviewed 104 colorectal cancer patients treated with standard chemotherapy with bevacizumab and examined the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac5cab6e28e8c77a09d9652039ef7c7
https://doi.org/10.1093/jjco/hyr006
https://doi.org/10.1093/jjco/hyr006
Publikováno v:
Respirology. 16:326-331
Background and objective: Combined pulmonary fibrosis and emphysema (CPFE) is a unique disorder of the upper lobe, whereas emphysema is usually associated with lower lobe fibrosis. Although CPFE might increase the risk of lung cancer, the prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::238974f44ea92e13772ebc2984aab189
https://doi.org/10.1111/j.1440-1843.2010.01907.x
https://doi.org/10.1111/j.1440-1843.2010.01907.x
Autor:
Toshiaki Takahashi, Nobuyuki Yamamoto, Yukiko Nakamura, Hideo Kunitoh, John R. Baldwin, Yuichiro Ohe, Noboru Yamamoto, Takehito Shukuya, Minori Koshiji, Tomohide Tamura, Hiroshi Nokihara, Haruyasu Murakami, Chiharu Tanai
Publikováno v:
Journal of Thoracic Oncology. 5(7):1068-1074
Introduction Enzastaurin is an oral serine/threonine kinase inhibitor, which suppress signaling through protein kinase C-β and the phosphatidylinositol 3-kinase/AKT pathway. Preclinical studies suggested synergic antitumor activity of enzastaurin an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b37ba4d20ff25de7dc751c93c1e4d22
Autor:
Yoshiaki Mori, Kiyotaka Yoh, Young Hak Kim, Hiroshi Isobe, Terufumi Kato, Makoto Nishio, Hideo Kunitoh, Yoshio Tomizawa, Yukio Hosomi, Koichi Minato, Yasuo Ohashi, Yasushi Goto, Hiroshi Sakai, Yoshinori Hasegawa, Kazuhiko Yamada, Akira Inoue, Takayuki Kaburagi, Chiharu Tanai
Publikováno v:
ESMO Open
Background Some patients with advanced or recurrent, epidermal growth factor receptor (EGFR) mutation-positive (EGFR M+) non-small-cell lung cancer (NSCLC) continue to receive EGFR tyrosine kinase inhibitors (TKIs) beyond radiological progression. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb50235f832c97efc6e7f7f2531121f
https://doi.org/10.1136/esmoopen-2017-000214
https://doi.org/10.1136/esmoopen-2017-000214
Autor:
Yoshiaki Tanaka, Sayaka Ohara, Hiromichi Noda, Mariko Gunji, Chiharu Tanai, Tomonori Ushijima, Kazuhiro Usui, Hajime Horiuchi
Publikováno v:
Journal of Medical Case Reports
Introduction Non-small-cell lung cancer harboring an activated epidermal growth factor receptor mutation exhibits a good response to epidermal growth factor receptor-tyrosine kinase inhibitors; however, clinicians often experience treatment failure f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b294deaef1706536c4df56f19970a8b
https://doi.org/10.1186/1752-1947-8-64
https://doi.org/10.1186/1752-1947-8-64